Senti Biosciences (SNTI) appoints Feng Hsiung to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Senti Biosciences (SNTI) appoints Feng Hsiung to Board

Senti Bio Appoints Feng Hsiung to Board of Directors

March 13, 2025 4:01 PM EDT

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (Senti Bio, or the Company), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it has appointed Feng Hsiung, an executive with extensive business, finance and investment experience, to the Senti Bio Board of Directors (the Board).

We are pleased to welcome Feng to our Boardhe brings deep expertise in investment strategy and capital markets across multiple industries, said Timothy Lu, M.D., Ph.D., CEO of Senti Bio. We look... More